Batch BeaconUK recalls and safety alerts

Medicines recallMHRA

Depo-Medrone 80 mg in 2 mL, Maxearn Limited recalled over a strength or dose problem

Wrong strength or doseHigh riskClass 2

A batch of Depo-Medrone has been released to the market with an error. The vial over label incorrectly states that the total vial content is 40 mg in 1 mL, when the correct total vial content is 80mg in 2 mL (with a concentration of 40mg/ml of methylprednisolone acetate).

Check your product

Only products that match these details are covered. Have your pack in front of you.

3 identifiers listed for this notice.

  • Depo-Medrone 80 mg in 2 mL, Maxearn Limited 2mL

    Batch codePrinted on the pack, often next to the date mark. It may start with L or LOT.
    • LG3883 Max 0943Y
    ExpiryOn the carton, blister or label.
    • 29/02/2029
    First distributedOn the product, its label or its packaging.
    • 13/05/2025

What to do now

The problem with Depo-Medrone 80 mg in 2 mL, Maxearn Limited is strength: the dose in the affected batches may be higher or lower than the label says.

  1. Keep taking your medicine unless a healthcare professional tells you otherwise.
  2. Check the batch number and expiry date on your pack against the list on this page.
  3. If it matches, your pharmacist can swap it or arrange an alternative.
  4. Report suspected side effects to the MHRA Yellow Card scheme.

Why it matters. A medicine that is weaker than stated may not control the condition it treats; one that is stronger may cause side effects.

Symptoms and when to get help

Look out for

  • a side effect you have not had before
  • your condition not being controlled as well as usual

Get help urgently

  • signs of a severe allergic reaction, such as swelling of the face or throat or difficulty breathing — call 999
  • if you feel unwell and are worried, speak to a pharmacist, your GP or NHS 111

This is general information based on NHS public guidance, not medical advice. In an emergency call 999. For urgent advice use NHS 111 (NHS 24 on 111 in Scotland) or, in Northern Ireland, your GP or out-of-hours service.

Replacements and prescriptions

Talk to the pharmacist who dispensed the medicine. They have the batch information and can arrange a replacement.

If you bought it over the counter, return it to the pharmacy or shop for a refund or replacement.

From the official notice

Published by the Medicines and Healthcare products Regulatory Agency (EL(25)A/29). Quoted as issued.

Summary

A batch of Depo-Medrone has been released to the market with an error. The vial over label incorrectly states that the total vial content is 40 mg in 1 mL, when the correct total vial content is 80mg in 2 mL (with a concentration of 40mg/ml of methylprednisolone acetate).

The risk

DMRC reference number DMRC-35933447 Marketing Authorisation Holder

Advice for healthcare professionals

Stop supplying the above batch immediately. Quarantine all stock and return it to your supplier using your supplier’s approved process.

Maxearn can confirm 32 packs were released by the distributor. All other units have been held before onward distribution. Maxearn will arrange for customers who received these units to be contacted.

Healthcare professionals who have been supplied this batch and have administered the medicine to patients should contact the patient to make them aware of this error and provide any relevant clinical advice.

No further action is required by patients as this is a Pharmacy and Wholesaler level recall. Depo-Medrone is administered under the supervision of a healthcare professional. Patients who have received this batch will be contacted by your healthcare professional.

Patients who experience adverse reactions or have any questions about the medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme .

Advice for patients

No further action is required by patients as this is a Pharmacy and Wholesaler level recall. Depo-Medrone is administered under the supervision of a healthcare professional. Patients who have received this batch will be contacted by your healthcare professional.

Patients who experience adverse reactions or have any questions about the medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme .

Open the MHRA notice

Questions

Why has Depo-Medrone 80 mg in 2 mL, Maxearn Limited been recalled?

The problem with Depo-Medrone 80 mg in 2 mL, Maxearn Limited is strength: the dose in the affected batches may be higher or lower than the label says. A medicine that is weaker than stated may not control the condition it treats; one that is stronger may cause side effects.

How do I know if my medicine is affected?

Compare the batch code, expiry and date code on your pack with the details listed under “Check your product” on this page. Only items that match are covered by the notice.

What should I do now?

Keep taking your medicine unless a healthcare professional tells you otherwise. Check the batch number and expiry date on your pack against the list on this page.

Do I need a new prescription?

Talk to the pharmacist who dispensed the medicine. They have the batch information and can arrange a replacement. If you bought it over the counter, return it to the pharmacy or shop for a refund or replacement.

Related notices